Human Molecular Genetics, Vol 5, 1813-1822, Copyright © 1996 by Oxford University Press
A Nestorowicz, BA Wilson, KP Schoor, H Inoue, B Glaser, H Landau, CA Stanley, PS Thornton, JP Clement 4th, J Bryan, L Aguilar-Bryan and MA Permutt
Familial hyperinsulinism (HI) is a disorder of pancreatic beta-cell
function characterized by persistent hyperinsulinism despite severe
hypoglycemia. To define the molecular genetic basis of HI in Ashkenazi
Jews, 25 probands were screened for mutations in the sulfonylurea receptor
(SUR1) gene by single-strand conformation polymorphism (SSCP) analysis of
genomic DNA and subsequent nucleotide sequence analyses. Two common
mutations were identified: (I) a novel in-frame deletion of three
nucleotides (nt) in exon 34, resulting in deletion of the codon for F1388
(delta F1388) and (II) a previously described g-->a transition at
position-9 of the 3' splice site of intron 32 (designated 3992-9g-->a).
Together, these mutations are associated with 88% of the HI chromosomes of
the patients studied. 86Rb+ efflux measurements of COSm6 cells
co-expressing Kir6.2 and either wild-type or delta F1388 SUR1 revealed that
the F1388 mutation abolished ATP-sensitive potassium channel (KATP)
activity in intact cells. Extended haplotype analyses indicated that the
delta F1388 mutation was associated with a single specific haplotype
whereas the 3992-9g-->a mutation was primarily associated with a single
haplotype but also occurred in the context of several other different
haplotypes. These data suggest that HI in Ashkenazi Jews is predominantly
associated with mutations in the SUR1 gene and provide evidence for the
existence of at least two founder HI chromosomes in this population.
ARTICLES
Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews
Division of Endocrinology, Diabetes and Metabolism, Washington University School of Medicine, St Louis, MO 63110, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K Mazor-Aronovitch, D Gillis, D Lobel, H J Hirsch, O Pinhas-Hamiel, D Modan-Moses, B Glaser, and H Landau Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism Eur. J. Endocrinol., October 1, 2007; 157(4): 491 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Suzuki, Y. Makita, T. Mukai, K. Matsuo, O. Ueda, and K. Fujieda Molecular Basis of Neonatal Diabetes in Japanese Patients J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3979 - 3985. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Valayannopoulos, M. Vaxillaire, Y. Aigrain, F. Jaubert, C. Bellanne-Chantelot, M.-J. Ribeiro, F. Brunelle, P. Froguel, J.-J. Robert, M. Polak, et al. Coexistence in the Same Family of Both Focal and Diffuse Forms of Hyperinsulinism Diabetes Care, June 1, 2007; 30(6): 1590 - 1592. [Full Text] [PDF] |
||||
![]() |
I. Giurgea, C. Sempoux, C. Bellanne-Chantelot, M. Ribeiro, L. Hubert, N. Boddaert, J.-M. Saudubray, J.-J. Robert, F. Brunelle, J. Rahier, et al. The Knudson's Two-Hit Model and Timing of Somatic Mutation May Account for the Phenotypic Diversity of Focal Congenital Hyperinsulinism J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4118 - 4123. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hussain, M. Seppanen, K. Nanto-Salonen, N. S. Adzick, C. A. Stanley, P. Thornton, and H. Minn The Diagnosis of Ectopic Focal Hyperinsulinism of Infancy with [18F]-Dopa Positron Emission Tomography J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2839 - 2842. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Giurgea, D Sanlaville, J-C Fournet, C Sempoux, C Bellanne-Chantelot, G Touati, L Hubert, M-S Groos, F Brunelle, J Rahier, et al. Congenital hyperinsulinism and mosaic abnormalities of the ploidy J. Med. Genet., March 1, 2006; 43(3): 248 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. Lin, C. MacMullen, A. Ganguly, C. A. Stanley, and S.-L. Shyng A Novel KCNJ11 Mutation Associated with Congenital Hyperinsulinism Reduces the Intrinsic Open Probability of beta-Cell ATP-sensitive Potassium Channels J. Biol. Chem., February 3, 2006; 281(5): 3006 - 3012. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hussain, J. Bryan, H. T. Christesen, K. Brusgaard, and L. Aguilar-Bryan Serum Glucagon Counterregulatory Hormonal Response to Hypoglycemia Is Blunted in Congenital Hyperinsulinism Diabetes, October 1, 2005; 54(10): 2946 - 2951. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Giurgea, T. Ulinski, G. Touati, C. Sempoux, F. Mochel, F. Brunelle, J.-M. Saudubray, C. Fekete, and P. de Lonlay Factitious Hyperinsulinism Leading to Pancreatectomy: Severe Forms of Munchausen Syndrome by Proxy Pediatrics, July 1, 2005; 116(1): e145 - e148. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Ribeiro, P. De Lonlay, T. Delzescaux, N. Boddaert, F. Jaubert, S. Bourgeois, F. Dolle, C. Nihoul-Fekete, A. Syrota, and F. Brunelle Characterization of Hyperinsulinism in Infancy Assessed with PET and 18F-Fluoro-L-DOPA J. Nucl. Med., April 1, 2005; 46(4): 560 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Seebohm Activators of Cation Channels: Potential in Treatment of Channelopathies Mol. Pharmacol., March 1, 2005; 67(3): 585 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Henwood, A. Kelly, C. MacMullen, P. Bhatia, A. Ganguly, P. S. Thornton, and C. A. Stanley Genotype-Phenotype Correlations in Children with Congenital Hyperinsulinism Due to Recessive Mutations of the Adenosine Triphosphate-Sensitive Potassium Channel Genes J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 789 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tornovsky, A. Crane, K. E. Cosgrove, K. Hussain, J. Lavie, M. Heyman, Y. Nesher, N. Kuchinski, E. Ben-Shushan, O. Shatz, et al. Hyperinsulinism of Infancy: Novel ABCC8 and KCNJ11 Mutations and Evidence for Additional Locus Heterogeneity J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6224 - 6234. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Magge, S.-L. Shyng, C. MacMullen, L. Steinkrauss, A. Ganguly, L. E. L. Katz, and C. A. Stanley Familial Leucine-Sensitive Hypoglycemia of Infancy Due to a Dominant Mutation of the {beta}-Cell Sulfonylurea Receptor J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4450 - 4456. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Crane and L. Aguilar-Bryan Assembly, Maturation, and Turnover of KATP Channel Subunits J. Biol. Chem., March 5, 2004; 279(10): 9080 - 9090. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Giurgea, K. Laborde, G. Touati, C. Bellanne-Chantelot, M.-C. Nassogne, C. Sempoux, F. Jaubert, N. Khoa, V. Chigot, J. Rahier, et al. Acute Insulin Responses to Calcium and Tolbutamide Do Not Differentiate Focal from Diffuse Congenital Hyperinsulinism J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 925 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Stanley, P. S. Thornton, A. Ganguly, C. MacMullen, P. Underwood, P. Bhatia, L. Steinkrauss, L. Wanner, R. Kaye, E. Ruchelli, et al. Preoperative Evaluation of Infants with Focal or Diffuse Congenital Hyperinsulinism by Intravenous Acute Insulin Response Tests and Selective Pancreatic Arterial Calcium Stimulation J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 288 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. DUNNE, K. E. COSGROVE, R. M. SHEPHERD, A. AYNSLEY-GREEN, and K. J. LINDLEY Hyperinsulinism in Infancy: From Basic Science to Clinical Disease Physiol Rev, January 1, 2004; 84(1): 239 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Thornton, C. MacMullen, A. Ganguly, E. Ruchelli, L. Steinkrauss, A. Crane, L. Aguilar-Bryan, and C. A. Stanley Clinical and Molecular Characterization of a Dominant Form of Congenital Hyperinsulinism Caused by a Mutation in the High-Affinity Sulfonylurea Receptor Diabetes, September 1, 2003; 52(9): 2403 - 2410. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Stanley Advances in Diagnosis and Treatment of Hyperinsulinism in Infants and Children J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4857 - 4859. [Full Text] [PDF] |
||||
![]() |
H. Huopio, J. Jaaskelainen, J. Komulainen, R. Miettinen, P. Karkkainen, M. Laakso, P. Tapanainen, R. Voutilainen, and T. Otonkoski Acute Insulin Response Tests for the Differential Diagnosis of Congenital Hyperinsulinism J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4502 - 4507. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huopio, S.-L. Shyng, T. Otonkoski, and C. G. Nichols KATP channels and insulin secretion disorders Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E207 - E216. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, B. R. Gauthier, K. A. Hagenfeldt-Johansson, M. Iezzi, and C. B. Wollheim Foxa2 (HNF3beta ) Controls Multiple Genes Implicated in Metabolism-Secretion Coupling of Glucose-induced Insulin Release J. Biol. Chem., May 10, 2002; 277(20): 17564 - 17570. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dekel, D. Lubin, D. Modan-Moses, J. Quint, B. Glaser, and J. Meyerovitch Compound Heterozygosity for the Common Sulfonylurea Receptor Mutations Can Cause Mild Diazoxide-Sensitive Hyperinsulinism Clinical Pediatrics, April 1, 2002; 41(3): 183 - 186. [Abstract] [PDF] |
||||
![]() |
H. B.T. Christesen, B. B. Jacobsen, S. Odili, C. Buettger, A. Cuesta-Munoz, T. Hansen, K. Brusgaard, O. Massa, M. A. Magnuson, C. Shiota, et al. The Second Activating Glucokinase Mutation (A456V): Implications for Glucose Homeostasis and Diabetes Therapy Diabetes, April 1, 2002; 51(4): 1240 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kassem, I. Ariel, P. S. Thornton, K. Hussain, V. Smith, K. J. Lindley, A. Aynsley-Green, and B. Glaser p57KIP2 Expression in Normal Islet Cells and in Hyperinsulinism of Infancy Diabetes, December 1, 2001; 50(12): 2763 - 2769. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Sund, M. Z. Vatamaniuk, M. Casey, S.-L. Ang, M. A. Magnuson, D. A. Stoffers, F. M. Matschinsky, and K. H. Kaestner Tissue-specific deletion of Foxa2 in pancreatic {beta} cells results in hyperinsulinemic hypoglycemia Genes & Dev., July 1, 2001; 15(13): 1706 - 1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Fournet, C. Mayaud, P. de Lonlay, M.-S. Gross-Morand, V. Verkarre, M. Castanet, M. Devillers, J. Rahier, F. Brunelle, J.-J. Robert, et al. Unbalanced Expression of 11p15 Imprinted Genes in Focal Forms of Congenital Hyperinsulinism : Association with a Reduction to Homozygosity of a Mutation in ABCC8 or KCNJ11 Am. J. Pathol., June 1, 2001; 158(6): 2177 - 2184. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. MacMullen, J. Fang, B. Y. L. Hsu, A. Kelly, P. de Lonlay-Debeney, J.-M. Saudubray, A. Ganguly, T. J. Smith, and C. A. Stanley Hyperinsulinism/Hyperammonemia Syndrome in Children with Regulatory Mutations in the Inhibitory Guanosine Triphosphate-Binding Domain of Glutamate Dehydrogenase J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1782 - 1787. [Abstract] [Full Text] |
||||
![]() |
M. A. Permutt, J. C. Wasson, B. K. Suarez, J. Lin, J. Thomas, J. Meyer, S. Lewitzky, J. S. Rennich, A. Parker, L. DuPrat, et al. A Genome Scan for Type 2 Diabetes Susceptibility Loci in a Genetically Isolated Population Diabetes, March 1, 2001; 50(3): 681 - 685. [Abstract] [Full Text] |
||||
![]() |
E. A. Cartier, L. R. Conti, C. A. Vandenberg, and S.-L. Shyng Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy PNAS, February 27, 2001; 98(5): 2882 - 2887. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grimberg, R.J. Ferry Jr., A. Kelly, S. Koo-McCoy, K. Polonsky, B. Glaser, M.A. Permutt, L. Aguilar-Bryan, D. Stafford, P.S. Thornton, et al. Dysregulation of Insulin Secretion in Children With Congenital Hyperinsulinism due to Sulfonylurea Receptor Mutations Diabetes, February 1, 2001; 50(2): 322 - 328. [Abstract] [Full Text] |
||||
![]() |
C.-C. Shieh, M. Coghlan, J. P. Sullivan, and M. Gopalakrishnan Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities Pharmacol. Rev., December 1, 2000; 52(4): 557 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Thomas Neonatal Insulin Secretion and Persistent Hyperinsulinemia of Infancy NeoReviews, November 1, 2000; 1(11): e210 - 214. [Full Text] |
||||
![]() |
M. Nissim-Rafinia, O. Chiba-Falek, G. Sharon, A. Boss, and B. Kerem Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations Hum. Mol. Genet., July 22, 2000; 9(12): 1771 - 1778. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Glaser, P. Thornton, T. Otonkoski, and C. Junien Genetics of neonatal hyperinsulinism Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 79F - 86. [Abstract] [Full Text] |
||||
![]() |
R. M Shepherd, K. E Cosgrove, R. E O'Brien, P. D Barnes, C. Ämmälä, and M. J Dunne Hyperinsulinism of infancy: towards an understanding of unregulated insulin release Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 87F - 97. [Abstract] [Full Text] |
||||
![]() |
J Rahier, Y Guiot, and C Sempoux Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 108F - 112. [Full Text] |
||||
![]() |
M. R. ABRAHAM, A. JAHANGIR, A. E. ALEKSEEV, and A. TERZIC Channelopathies of inwardly rectifying potassium channels FASEB J, November 1, 1999; 13(14): 1901 - 1910. [Abstract] [Full Text] |
||||
![]() |
L. E. Levitt Katz, R. J. Ferry Jr., C. A. Stanley, P. F. Collett-Solberg, L. Baker, and P. Cohen Suppression of Insulin Oversecretion by Subcutaneous Recombinant Human Insulin-Like Growth Factor I in Children with Congenital Hyperinsulinism Due to Defective {beta}-Cell Sulfonylurea Receptor J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3117 - 3124. [Abstract] [Full Text] |
||||
![]() |
C. Hernandez-Sanchez, Y. Ito, J. Ferrer, M. Reitman, and D. LeRoith Characterization of the Mouse Sulfonylurea Receptor 1 Promoter and Its Regulation J. Biol. Chem., June 25, 1999; 274(26): 18261 - 18270. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. de Lonlay-Debeney, F. Poggi-Travert, J.-C. Fournet, C. Sempoux, C. D. Vici, F. Brunelle, G. Touati, J. Rahier, C. Junien, C. Nihoul-Fekete, et al. Clinical Features of 52 Neonates with Hyperinsulinism N. Engl. J. Med., April 15, 1999; 340(15): 1169 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Aguilar-Bryan and J. Bryan Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels Endocr. Rev., April 1, 1999; 20(2): 101 - 135. [Abstract] [Full Text] |
||||
![]() |
C. A. Stanley, Y. K. Lieu, B. Y.L. Hsu, A. B. Burlina, C. R. Greenberg, N. J. Hopwood, K. Perlman, B. H. Rich, E. Zammarchi, and M. Poncz Hyperinsulinism and Hyperammonemia in Infants with Regulatory Mutations of the Glutamate Dehydrogenase Gene N. Engl. J. Med., May 7, 1998; 338(19): 1352 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Glaser, P. Kesavan, M. Heyman, E. Davis, A. Cuesta, A. Buchs, C. A. Stanley, P. S. Thornton, M. A. Permutt, F. M. Matschinsky, et al. Familial Hyperinsulinism Caused by an Activating Glucokinase Mutation N. Engl. J. Med., January 22, 1998; 338(4): 226 - 230. [Full Text] [PDF] |
||||
![]() |
M. J. Higgins, C. D. Day, N. J. Smilinich, L. Ni, P. R. Cooper, N. J. Nowak, C. Davies, P. J. de Jong, F. Hejtmancik, G. A. Evans, et al. Contig Maps and Genomic Sequencing Identify Candidate Genes in the Usher 1C Locus Genome Res., January 1, 1998; 8(1): 57 - 68. [Abstract] [Full Text] |
||||
![]() |
M. Matsuo, S. Trapp, Y. Tanizawa, N. Kioka, T. Amachi, Y. Oka, F. M. Ashcroft, and K. Ueda Functional Analysis of a Mutant Sulfonylurea Receptor, SUR1-R1420C, That Is Responsible for Persistent Hyperinsulinemic Hypoglycemia of Infancy J. Biol. Chem., December 22, 2000; 275(52): 41184 - 41191. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Partridge, D. J. Beech, and A. Sivaprasadarao Identification and Pharmacological Correction of a Membrane Trafficking Defect Associated with a Mutation in the Sulfonylurea Receptor Causing Familial Hyperinsulinism J. Biol. Chem., September 14, 2001; 276(38): 35947 - 35952. [Abstract] [Full Text] [PDF] |
||||






















